Connected Medical Device Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Connected medical devices, also referred to as Internet of Medical Things (IoMT) devices, include wearables, implantable monitors, point-of-care diagnostics, and infusion pumps capable of transmitting health data in real time to clinicians and electronic health record systems. The broader global medical devices market was valued at approximately $679 billion in 2025 and is expected to reach roughly $1.2 trillion by 2035. Within this, connected devices represent a high-growth subset, with various industry analyses converging on a 2025 market size in the $57-76 billion range and projecting values between $159 billion and $265 billion by the early 2030s.

• •The global connected medical device market is valued at approximately $76 billion in 2025, with forecasts suggesting it could reach $159-265 billion by 2031-2035 depending on scope and methodology.
• •This market is part of a broader global medical devices sector estimated at $679 billion in 2025, growing toward $1.2 trillion by 2035 at a CAGR of approximately 6%.
• •The connected medical device security solutions sub-market is valued at roughly $2 billion in 2025 and is projected to reach $10.9 billion by 2035 at a 19% CAGR, reflecting the rising importance of IoMT cybersecurity.
• •Medical device connectivity infrastructure, including wireless hardware, middleware, and network systems, represents a related fast-growing segment projected at a 26% CAGR through 2033.

The market's expansion is fueled by several interconnected forces: the aging of the global population, the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, and growing pressure on healthcare systems to contain costs through preventive and outpatient care. The proliferation of remote patient monitoring (RPM) programs, dramatically accelerated by the COVID-19 pandemic, has normalized the use of at-home connected devices that transmit data to care teams without requiring in-person visits. Declining costs of sensors, processors, and wireless communication modules have made connected functionality economically viable across a broader range of device categories, from consumer wearables to clinical-grade monitors. Artificial intelligence integration is amplifying the value of connected devices by enabling real-time analytics, predictive alerts, and automated clinical decision support.

• •An aging global population and rising chronic disease prevalence are increasing demand for continuous health monitoring solutions that can operate outside traditional hospital settings.
• •Remote patient monitoring adoption continues to expand as healthcare payers and providers seek to reduce hospital readmissions and enable value-based care delivery models.
• •Falling costs of sensors and wireless connectivity components have lowered the price barrier for embedding connectivity into a wider range of medical devices.
• •AI and machine learning capabilities are being integrated into connected devices to provide real-time data analysis, anomaly detection, and clinical decision support.

North America holds the largest regional share of the connected medical devices market, supported by advanced healthcare infrastructure, favorable reimbursement policies for RPM services, and strong technology adoption among both providers and patients. Europe represents a significant second market, with the European Union actively promoting digital health initiatives and interoperability standards through programs such as the Digital Health Europe initiative. The Asia-Pacific region is the fastest-growing segment, driven by rising healthcare investment, expanding middle-class populations, and government digitization programs across countries including China, India, and Japan. By device type, the market spans wearable monitors, implantable devices, point-of-care diagnostic tools, and infusion systems, with remote monitoring wearables and cardiac monitors representing particularly high-volume categories.

• •North America leads the connected medical device market, supported by advanced healthcare IT infrastructure, established RPM reimbursement frameworks, and strong technology penetration in clinical settings.
• •Europe constitutes a major market with active EU-level digital health programs promoting interoperability and cross-border health data exchange standards.
• •Asia-Pacific is the fastest-growing regional market, fueled by rising healthcare expenditure, expanding insurance coverage, and government-supported digital health modernization initiatives.
• •Product categories include wearable monitors, implantable cardiac and neurological devices, point-of-care diagnostics, and smart infusion systems, with cardiac monitoring and glucose management representing some of the highest-volume connected device segments.

What are the recent trends and outlook?

Looking ahead, the market is expected to continue its strong growth trajectory, supported by ongoing healthcare digitization, the proliferation of 5G networks enabling more reliable real-time data transmission, and evolving regulatory frameworks that increasingly recognize and reimburse digital health solutions. Interoperability remains a critical challenge and opportunity, with industry standards such as FHIR (Fast Healthcare Interoperability Resources) gaining adoption as the foundation for seamless data exchange between connected devices and health IT systems. Cybersecurity concerns are receiving heightened regulatory and industry attention as the number of connected devices on hospital networks and in consumer homes continues to grow, creating a parallel security solutions market. The integration of edge computing and on-device AI processing is likely to accelerate, reducing latency in clinical decision-making and enabling more sophisticated real-time monitoring capabilities.

• •5G network deployment is expected to accelerate adoption by enabling more reliable, low-latency wireless connectivity for high-data-rate medical applications including remote surgery and real-time vital sign monitoring.
• •Regulatory bodies including the FDA and EMA are evolving frameworks for software as a medical device (SaMD) and AI-enabled connected devices, creating clearer pathways for market authorization of innovative products.
• •Cybersecurity and data privacy remain critical concerns, with growing regulatory requirements around IoMT device security driving investment in embedded security, encryption, and threat detection solutions.
• •Interoperability standards such as HL7 FHIR are increasingly being adopted to enable seamless integration of connected device data across diverse electronic health record and health information exchange platforms.